The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma
Cancer Treatment and Research Communications · 2024
DOI: 10.1016/j.ctarc.2024.100856 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer Treatment and Research Communications, 2024. Verfasst von Andrew C Kidd und 6 weiteren Autor:innen. Beteiligte Einrichtung: Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK; School of Cancer Sciences, University of Glasgow, UK. Hauptthemen laut MEDLINE: Sarcopenia, Pleural Neoplasms, Mesothelioma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Lung Foundation.
Abstract (Originalsprache)
INTRODUCTION: Altered body composition is associated with adverse survival in multiple cancers. We determined the prevalence, prognostic significance and clinicopathological correlates of sarcopenia and adipopenia in Pleural Mesothelioma (PM) patients receiving chemotherapy. METHODS: We performed a multi-centre retrospective cohort study. Clinical data and CT images were retrieved for 111 patients from 4 UK centres. Skeletal muscle (at L3 and T4) and fat tissue areas (at L3 only) were measured on pre- and post-chemotherapy CT scans (ImageJ software) and normalised for height. Pre-chemotherapy sarcopenia and adipopenia were defined using validated thresholds, where available or indices
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK; School of Cancer Sciences, University of Glasgow, UK.
- School of Cancer Sciences, University of Glasgow, UK; Department of Radiology, Queen Elizabeth University Hospital, Glasgow, UK.
- Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK.
- University of Leicester, UK.
- Wythenshawe Hospital, Manchester, UK; Manchester Academic Health Science Centre (MAHSC), Faculty of Biology, Medicine & Health, University of Manchester, UK.
- Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK; School of Cancer Sciences, University of Glasgow, UK. Electronic address: kevin.blyth@glasgow.ac.uk.
Förderung
- British Lung Foundation
Zitieren
APA
Kidd, A. C., Cowell, G. W., Martin, G. A., Ferguson, J., Fennell, D. A., Evison, M., & Blyth, K. G. (2024). The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2024.100856
Vancouver
Kidd AC, Cowell GW, Martin GA, Ferguson J, Fennell DA, Evison M, et al. The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma. Cancer Treatment and Research Communications. 2024. doi:10.1016/j.ctarc.2024.100856
BibTeX
@article{Kidd2024,
author = {Kidd, Andrew C and Cowell, Gordon W and Martin, Geoffrey A and Ferguson, Jenny and Fennell, Dean A and Evison, Matt and Blyth, Kevin G},
title = {The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma},
journal = {Cancer Treatment and Research Communications},
year = {2024},
doi = {10.1016/j.ctarc.2024.100856}
}
EUVIMED